Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

EONS Poster diplay

1672 - EONS Poster - Incidence and risk factors of phlebitis in patients with peripheral parenteral nutrition administration.


22 Oct 2018


EONS Poster diplay


Management of Systemic Therapy Toxicities;  Supportive Care and Symptom Management

Tumour Site


Seung Yoon Oh


Annals of Oncology (2018) 29 (suppl_8): viii695-viii697. 10.1093/annonc/mdy277


S.Y. Oh1, J.M. Lee1, J.W. Kim1, S.H. Kim1, J.M. Park1, G.Y. Yeo1, J.E. Hyun1, J. Park2

Author affiliations

  • 1 Nursing, Asan Medical Center, 138-736 - Seoul/KR
  • 2 College Of Nursing, Ajou University, 16499 - Suwon/KR


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 1672


Peripheral parenteral nutrition is one of the easiest ways to provide nutrition for patients who have difficulty with enteral nutrition. But, on the other hand it is attended with danger such as, phlebitis. The purpose of this study was to investigate incidence of phlebitis and its risk factors in patients with peripheral parenteral nutrition administration.


Prospective observational study was performed with 289 hospitalized adult patients with gastrointestinal diseases. The researchers evaluated peripheral venous catheter that administered peripheral parenteral nutrition until their removal and investigated the incidence of phlebitis using phlebitis scale of Infusion Nurses Society (2016). Logistic regression model was used to identify risk factors involved with occurrence of phlebitis. The statistical significance limits were set at p < 0.05.


The incidence of phlebitis was 37.0% (107 cases). Among them, Grade I was 24.6% (71 cases), Grade II was 12.4% (36 cases) and Grade III and IV did not occur. Platelet count (OR 2.13, CI 1.07-4.26, p=.032), nutrition infusion rate (OR 0.36, CI 0.16-0.79, p=.012) and infusion period (OR 1.02, CI 1.00-1.03, p=.033) had statistically significance with phlebitis occurrence.


Using peripheral parenteral nutrition must be carefully reconsidered for patients with risk factors of phlebitis. In using peripheral parenteral nutrition, adjusting infusion rate deserves to be considered with care. Moreover, in case of extension of peripheral parenteral nutrition therapy, medical team must regards using another way such as middle line or central line for nutrition therapy in a serious light.

Clinical trial identification

Legal entity responsible for the study

Asan Medical Center.


Has not received any funding.

Editorial Acknowledgement


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.